title: Criteria for prescribing dabigatrin extexilate and rivaroxaban really appropriate? Authors' reply.
authors.forename: Anne-Sophie
authors.initials: AS
authors.lastname: Larock
authors.forename: François
authors.initials: F
authors.lastname: Mullier
authors.forename: Jonathan
authors.initials: J
authors.lastname: Douxfils
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Dogné
authors.forename: Anne
authors.initials: A
authors.lastname: Spinewine
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001562:Benzimidazoles / Q000009:adverse effects*; D005260:Female; D006801:Humans; D057970:Inappropriate Prescribing; D008297:Male; D009025:Morpholines / Q000009:adverse effects*; D011725:Pyridines / Q000009:adverse effects*; D013876:Thiophenes / Q000009:adverse effects*
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D009025:Morpholines; D011725:Pyridines; D013876:Thiophenes